This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Innovations and Contributions of Christopher G Danes
Introduction
Christopher G Danes is an innovative inventor based in the United States. He has made significant contributions to the field of medical research, particularly in understanding the effects of erythropoietin (EPO) on tumor progression and patient outcomes. Despite having no patents registered under his name, his research has the potential to influence therapeutic approaches in treating neurological insults and cancer.
Latest Patents
Danes' latest work focuses on the use of Eph-B4 and Ephrin-A1 for predicting negative physiological responses to EPO treatment. He has disclosed a novel tissue protective EPO binding receptor protein complex, termed NEPOR. The presence of NEPOR components on tumors allows EPO to impact the survival of associated cells, thereby enhancing tumor progression and negatively affecting patient survival. His research outlines methods for identifying and designing NEPOR modulating therapeutics, which could lead to improved treatment strategies for conditions such as stroke and cancer.
Career Highlights
Throughout his career, Christopher G Danes has worked with notable organizations, including Molecular Health GmbH and the University of Texas System. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Danes has collaborated with various research institutions and companies, enhancing his work's impact on medical science. His partnerships have facilitated the exploration of NEPOR as a
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile